Researchers tested different formulations of cationic fusogenic liposomes to determine how their charge density and lipid composition influenced fusion efficiency and membrane effects. They varied ...

Objective This study aimed to establish HAV and HEV infections in multiple small animals by intravenously injecting lipid nanoparticle (LNP)-encapsulated full-length viral RNAs (LNP-vRNA). Design In ...

The companies specifically claim that Moderna uses their patented lipid nanoparticle (LNP) delivery technology, which is key to ensuring mRNA doesn’t degrade in the body, in its COVID-19 vaccine ...

March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle ... protecting their innovative LNP technology ...

Roivant Sciences (Nasdaq: ROIV) portfolio company Genevant Sciences and Canada’s Arbutus Biopharma (Nasdaq: ABUS) yesterday filed five international lawsuits seeking to enforce patents protecting ...

ABUS), have initiated international legal actions against Moderna (NASDAQ:MRNA), Inc., alleging infringement of patents related to their lipid nanoparticle (LNP) technology. The companies are seeking ...

March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid ... innovative LNP technology against Moderna, Inc ...